Articles Tagged with ''Dow AgroSciences''

Dow AgroSciences works to develop low-drift formulations

08/30/17 6:45 AM By Steve Davies

WASHINGTON, Aug. 30, 2017 – Considering the problems farmers and applicators – and manufacturers – are experiencing with dicamba this year, one could reasonably wonder whether it makes sense to bet on its future in agriculture. But Dow AgroSciences is making that wager.

EPA goes after Times on chlorpyrifos

08/21/17 5:21 PM By Steve Davies

WASHINGTON, Aug. 21, 2017 - The EPA is pushing back against a New York Times report that describes some of the internal deliberations leading up to the agency’s decision to deny a petition that sought to ban the widely used pesticide chlorpyrifos.

China OKs two GMO products for import

07/17/17 2:45 PM By Steve Davies

WASHINGTON, July 17, 2017 - China has approved two more genetically modified products for import, which should leave four products awaiting decisions from the Chinese Ministry of Agriculture (MOA). But Dow AgroSciences said today that the ministry is now saying that Enlist soybeans are not covered by a 100-day economic action plan initiated by the U.S. and Chinese governments in April.

Enlist corn on the way as China approves trait

06/14/17 5:22 PM By Steve Davies

WASHINGTON, June 14, 2017 – Corn growers in the U.S. and Canada will have a new option next year when Dow AgroSciences launches Enlist Corn, engineered to be resistant to the company’s Enlist Duo herbicide, which contains glyphosate and the choline salt of 2,4-D.

ChemChina’s purchase of Syngenta gets shareholder approval

05/05/17 12:18 PM By Steve Davies

WASHINGTON, May 5, 2017 - Syngenta shareholders have accepted ChemChina’s $43 billion offer to buy the company, tendering more than enough shares to allow the transaction to go forward.

Agribusinesses seek delay in endangered species evaluations

04/20/17 5:00 PM By Steve Davies

WASHINGTON, April 20, 2017 - Three agribusinesses have asked the Interior and Commerce departments to stop analyzing the effects of three widely used organophosphate insecticides on endangered species, arguing that EPA evaluations provided to the agencies have overstated the risks of the chemicals to wildlife and that the process used by federal agencies to analyze the risks of pesticides to endangered species is deeply flawed.

EPA rejects petition to revoke chlorpyrifos tolerances

03/29/17 10:03 PM By Steve Davies

WASHINGTON, March 29, 2017 - The Environmental Protection Agency has decided to continue allowing the use of the insecticide chlorpyrifos, stating that the science surrounding human health effects is too uncertain to justify its own proposed ban on food tolerances.

$455 million award to Bayer affirmed in patent lawsuit

03/02/17 5:00 PM By Steve Davies

WASHINGTON, March 2, 2017 - Dow AgroSciences is on the hook for $455 million in payments to Bayer CropScience after a federal appeals court upheld a patent infringement award involving a gene used in glufosinate-tolerant seed.

Newsmakers

View More Videos

Agri-Pulse Newsmakers

04.19.2024

Agri-Pulse Newsmakers: April 19, 2024: Rep. Salud Carbajal, D-Calif., on farm bill, specialty crops

California Democrat Salud Carbajal sits on the House Ag Committee and is working on his first farm bill. He joins us to discuss the latest politics surrounding a farm bill timeline and whether or not the House Ag Committee can meet a Memorial Day deadline proposed by House Ag Chairman Glenn “GT” Thompson, R-Pa. He also discusses the challenges facing the specialty crop industry and how mechanization can be used to help workforce shortages.

Then, Dennis Nuxoll with the Western Growers Association and Tom Sell with Combest, Sell & Associates join to chat about the political environment facing a farm bill and challenges facing specialty crop producers.

Want to receive Newsmakers in your inbox every week? Sign up! http://eepurl.com/hTgSAD

Editorial Office - Washington, DC	Sales, Billing & Customer Service- Camdenton, MO
Suite 436A	110 Waterside Lane
1400 Independence Ave. SW	Camdenton, MO 65020
Washington, DC 20250	(573) 873-0800

	Editorial Office - Sacramento, CA
	(916) 402-9227